MedPath

Radio protective effect of royal jelly against ionizing-radiatio

Not Applicable
Conditions
Condition 1: Male infertility. Condition 2: Radiation exposure. Condition 3: Ionizing radiation exposure.
Male infertility
Exposure to radiation
Exposure to ionizing radiation
Registration Number
IRCT2014090819091N1
Lead Sponsor
Babol university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
30
Inclusion Criteria

men; at the age of 20 to 45 year old; Exclusion criteria: having a history of cancer; autoimmune diseases; having allergy to bee sting, to honey, to royal jelly and pollen; having a history of smoking; radiotherapy; chemotherapy; nuclear medicine scan; antibiotic therapy during last three months before attending the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ymphocyte DNA tail length. Timepoint: A)On admission B)Two weeks after oral administration of royal jelly. Method of measurement: Visual scoring of DNA tail.
Secondary Outcome Measures
NameTimeMethod
Sperm count in semen sample. Timepoint: A)On admission B)75 days after oral administration of royal jelly. Method of measurement: Hemocytometer.;Gamma radiation dose. Timepoint: A)On admission B)75 days after oral administration of royal jelly. Method of measurement: in Gy scale measured by gamma radiation dosimeter.;Sperm morphology in semen sample. Timepoint: A)On admission B)75 days after oral administration of royal jelly. Method of measurement: Hemocytometer.;Sperm motility in semen sample. Timepoint: A)On admission B)75 days after oral administration of royal jelly. Method of measurement: Hemocytometer.
© Copyright 2025. All Rights Reserved by MedPath